Schreiber, C., Sakuma, T., Izumiya, Y., Holditch, S., Hickey, R., Bressin, R., … Ikeda, Y. (2015). 41. U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction. In Molecular Therapy (Vol. 23, pp. S18–S18). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)33646-2

Schreiber, Claire, Toshie Sakuma, Yoshihiro Izumiya, Sara Holditch, Raymond Hickey, Robert Bressin, Upamanyu Basu, Kazunori Koide, Aravind Asokan, and Yasuhiro Ikeda. “41. U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction.” In Molecular Therapy, 23:S18–S18. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33646-2.

Schreiber C, Sakuma T, Izumiya Y, Holditch S, Hickey R, Bressin R, et al. 41. U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction. In: Molecular Therapy. Elsevier BV; 2015. p. S18–S18.

Schreiber, Claire, et al. “41. U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction.” Molecular Therapy, vol. 23, Elsevier BV, 2015, pp. S18–S18. Crossref, doi:10.1016/s1525-0016(16)33646-2.

Schreiber C, Sakuma T, Izumiya Y, Holditch S, Hickey R, Bressin R, Basu U, Koide K, Asokan A, Ikeda Y. 41. U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction. Molecular Therapy. Elsevier BV; 2015. p. S18–S18.